INTRODUCTION
============

Growth hormone secretagogue receptor type 1a (GHSR1a) is a G protein--coupled receptor (GPCR) highly expressed in the hypothalamus ([@bib66]). Ghrelin, the natural GHSR1a agonist, is a potent growth hormone secretagogue, and it is the only known orexigenic peptide hormone ([@bib45]). Ghrelin-induced GHSR1a activation in soma and dendrites regulates gene transcription and increases electrical activity in neurons ([@bib45]; [@bib15]; [@bib17]; [@bib3]; [@bib56]; [@bib52]). In addition, GHSR1a activation modulates neurotransmitter release at presynaptic terminals ([@bib15]; [@bib16]; [@bib63]). The modulation of presynaptic voltage-gated calcium channels (Ca~V~2.1 and Ca~V~2.2) is a well-established mechanism by which GPCRs regulate neurotransmitter release at central synapses ([@bib11]; [@bib65]). However, the potential role of GHSR1a regulating Ca~V~2 channels has not been tested.

GHSR1a displays two uncommon features: a high constitutive activity and multiple signaling cascades that greatly increase the complexity of this receptor's function. Constitutive GHSR1a activity is ∼50% of the maximum activity triggered by saturating concentrations of ghrelin ([@bib23]), and it is proposed to contribute to the physiological roles of the ghrelin--GHSR1a system ([@bib48]). However, the mechanisms by which constitutive GHSR1a activity regulates neuronal activity in hypothalamic neurons remain poorly understood. On the other hand, despite the fact that it is well known that GHSR1a activates G~q~ proteins ([@bib24]; [@bib23]), recent reports indicate that other G proteins, such as G~i/o~ and G~12/13~, as well as G protein--independent pathways, such as β-arrestin recruitment, can mediate GHSR1a actions ([@bib6]; [@bib18]).

Here, we used a combination of genetic and pharmacological manipulations of GHSR1a activity to show that both constitutive and ghrelin-dependent GHSR1a activities inhibit Ca~V~2.1 and Ca~V~2.2. We found fundamental differences in the mechanisms of Ca~V~2 inhibition by constitutive and agonist-dependent modes of GHSR1a activation, including the signaling cascades involved and the fact that constitutive activity reduces membrane channel protein levels. Moreover, we found that GHSR1a impairs GABA release in hypothalamic neurons. Based on our data, we propose that this GHSR1a-depedent regulation of Ca~V~2 could modify presynaptic function in the hypothalamus, particularly under fasting, when GHSR1a expression is increased.

MATERIALS AND METHODS
=====================

Animals
-------

Sprague-Dawley rats and GHSR-eGFP reporter mice (STOCK Tg(Ghsr-EGFP)KZ65Gsat/Mmucd; 030942-UCD; Mouse Mutant Regional Resource Center, University of California, Davis, Davis, CA) were bred at the animal facility of the Instituto Multidisciplinario de Biología Celular (IMBICE). We housed the animals in a 12-h light--dark cycle in a climate-controlled room (22°C) with ad libitum access to water and food, except when indicated. We performed this study in strict accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals of the National Research Council, and all efforts were made to minimize suffering. All experimentation received approval from the Institutional Animal Care and Use Committee of the IMBICE. GHSR-eGFP reporter mice were provided by J. Zigman (University of Texas Southwestern Medical Center, Dallas, TX).

Rat neuronal primary cultures
-----------------------------

Neuronal cultures were obtained from Sprague-Dawley rats at embryonic days 16--17. The procedure protocol was similar to the one described in [@bib50]. In brief, we anesthetized pregnant rats with chloral hydrate (500 mg/kg) and removed the embryos. We exposed the embryo brains and placed them on the dorsal face to remove the hypothalamus with forceps. We placed the blocks of tissue in sterile Hanks' solution, and, after two washes, we dissociated the cells at 37°C for 20 min with Hanks' solution containing 0.25 mg/ml trypsin (Microvet) and 0.28 mg/ml deoxyribonuclease I from bovine pancreas (Sigma-Aldrich). Next, we added 300 µl FBS (Internegocios) to stop the enzyme digestion. We mechanically dissociated the cells using several glass pipettes with consecutive smaller-tip diameters. We plated 70,000 cells on 12-mm diameter glass coverslips treated previously with poly-[l]{.smallcaps}-lysine (Sigma-Aldrich) and laid over 24-well plates. We incubated the cells at 37°C in a 95% air and 5% CO~2~ atmosphere with Dulbecco's modified Eagle's medium (Microvet)/F12 1:1 medium supplemented with 10% FBS, 0.25% glucose, 2 mM glutamine (Gibco), 3.3 µg/ml insulin (Novo Nordisk Pharmaceutical Industries, Inc.), 5 U/ml penicillin G sodium salt (Richet), 5 µg/ml streptomycin (Richet), 40 µg/ml gentamicin sulfate salt (Richet), and 1% vitamin solution (Microvet). On the fourth day in culture, we replaced half of the incubation medium with fresh medium containing cytosine β-[d]{.smallcaps}-arabinofuranoside (Sigma-Aldrich) to reach a final concentration of 5 µM.

Mouse neuronal primary cultures
-------------------------------

We used GHSR-eGFP reporter mice at embryonic days 16--17. The procedure protocol was similar to the one described above. The culture conditions were the same except for the addition of B27 supplement (1:50; Gibco) to the incubation medium.

Rat neuron transfections
------------------------

At the sixth day in culture, we transfected rat neurons with GHSR1a-YFP--, GHSR1a-A204E-YFP--, or eGFP-containing plasmids using a calcium phosphate technique ([@bib27]). We performed patch-clamp recordings on green fluorescent and nongreen neurons after 48 h in culture.

Human embryonic kidney (HEK) 293T cell culture and transfection
---------------------------------------------------------------

For patch-clamp experiments, we cotransfected 80% confluent HEK 293T cells with GHSR1a or GHSR1a-A204E and Ca~V~2.1 (GenBank accession no. [AY714490](AY714490)) or Ca~V~2.2 (GenBank accession no. [AF055477](AF055477)), and the calcium channel auxiliary subunits Ca~V~α~2~δ~1~ (GenBank accession no. [AF286488](AF286488)) and Ca~V~β~3~ (GenBank accession no. [M88751](M88751)) or Ca~V~β~2a~ (GenBank accession no. [M80545](M80545)) in a 1:1:1:1 molar ratio using Lipofectamine 2000 (Invitrogen). Also, for GHSR1a constitutive activity studies, we decreased the amount of GHSR1a cDNA transfected as indicated in the Results. For some experiments, we cotransfected empty pcDNA3.1(+), the C-terminal GPCR kinase 2 (MAS-GRK2-ct) ([@bib28]; [@bib49]) or a Gα~q~ dominant-negative mutant (Gα~q~-Q209L/D277N; Missouri S&T cDNA Resource Center, Rolla, MO). For imaging experiments, we replaced Ca~V~2.1 and Ca~V~2.2 with these proteins tagged with GFP. GHSR1a and GHSR1a-A204E clones were provided by J. Marie (Université de Montpellier, Montpellier, France). Untagged Ca~V~ clones used for this study were provided by D. Lipscombe (Brown University, Providence, RI), and Ca~V~2.1-GFP was provided by E.S. Piedras-Renteria (Loyola University Chicago, Chicago, IL).

Fluorescein-ghrelin (F-ghrelin) binding
---------------------------------------

We transfected HEK 293T cells with 0.15 or 0.6 µg GHSR1a or 0.6 µg of empty pcDNA3.1+ plasmid as a control. We incubated the cells with 0.4 mM F-ghrelin ([@bib44]) in binding buffer (50 mM HEPES, pH 7.4, 5 mM MgCl~2~, 1 mM CaCl~2~, and 0.2% BSA, passed through a 0.45-µm filter). After 30 min, we washed the cells with PBS, fixed them with 4% formaldehyde, and covered them with mounting media. We observed the cells with a microscope (Eclipse 50i; Nikon) with a 500-nm filter. We took photomicrographs with a camera (DS-Ri1; Nikon) and analyzed the photomicrographs with ImageJ software (1.48v).

Electrophysiology
-----------------

We recorded ionic currents with an amplifier (Axopatch 200; Molecular Devices). We sampled data at 20 kHz and filtered it at 10 kHz (−3 dB) using pClamp8.2 software (Molecular Devices). We used recording electrodes with resistances between 2 and 4 MΩ when filled with internal solution. We admitted series resistances of \<6 MΩ and compensated 80% with a 10-µs lag time. We subtracted current leak online using a P/−4 protocol (except for the measure of evoked and miniature postsynaptic currents). We performed all recordings at room temperature.

### Sodium and barium currents of primary neuronal cultures.

We patch-clamped 7--10 d in vitro rat- and mouse-cultured neurons in voltage-clamp whole-cell mode. Internal pipette solution contained (mM): 134 CsCl, 10 EGTA, 1 EDTA, 10 HEPES, and 4 MgATP, pH 7.2 with CsOH. We measured sodium currents with high sodium external solution containing (mM): 135 NaCl, 4.7 KCl, 1.2 MgCl~2~, 2.5 CaCl~2~, 10 HEPES, and 10 glucose, pH 7.4 with NaOH. To measure Ca~V~ currents, we replaced the external solution by a high barium solution with the neurons clamped at negative potentials. High barium solution contained (mM): 10 BaCl~2~, 110 choline chloride, 20 tetraethyl-ammonium chloride, 1 MgCl~2~, 10 HEPES, 10 glucose, and 0.001 tetrodotoxin (TTX; Sigma-Aldrich), pH 7.4 with CsOH. We held neurons at −80 mV and applied test pulses to 0 mV for 20 ms every 10 s. I-V protocol: we applied increasing square test pulses of 20-ms duration ranging from −60 to 50 mV every 5 s ([@bib49]).

### Postsynaptic currents of primary neuronal cultures.

We patch-clamped 10--17 d in vitro mouse neurons. Internal pipette solution contained (mM): 115 Cs-methanesulfonate, 10 CsCl, 5 NaCl, 10 HEPES, 20 tetraethylammonium chloride, 4 Mg-ATP, 0.3 NaGTP, 0.6 EGTA, and 10 lidocaine *N*-ethyl bromide, pH 7.2 with CsOH. The external solution used was the high sodium solution described above, containing 10 µM 6-cyano-7-nitroquinoxaline-2,3-dione (Alomone Labs) to isolate inhibitory postsynaptic currents (IPSCs). To elicit evoked responses, we delivered electrical stimulation through parallel platinum electrodes (1-ms duration; amplitude, 20 mA) while neurons were held at −80 mV. We added 1 µM TTX to record miniature IPSCs (mIPSCs).

### Calcium currents of transiently transfected HEK 293T cells.

We performed whole-cell patch-clamp recordings on transfected HEK 293T cells. The internal solution was the same as that described for sodium and barium currents. External solution contained (mM): 2 CaCl~2~, 140 choline chloride, 1 MgCl~2~, 10 HEPES, pH 7.4 with CsOH. Test pulses protocol: we applied square pulses from −100 to 10 mV for 15 or 20 ms every 10 s. Prepulse protocol: we applied a prepulse of 15 ms at 80 mV 12.5 ms before the test pulse to effectively remove all voltage-dependent inhibition of Ca~V~ ([@bib49]; [@bib42]). This protocol has no effect on both Ca~V~2.1 and Ca~V~2.2 control current densities (Ca~V~2.1 currents without prepulse = −54.60 ± 16.97 pA/pF vs. with prepulse = −54.27 ± 16.92 pA/pF; *n* = 13; P \> 0.05; and Ca~V~2.2 currents without prepulse = −46.28 ± 14.53 pA/pF vs. with prepulse = −45.38 ± 14.23 pA/pF; *n* = 8; P \> 0.05; paired *t* tests). I-V protocol: we applied increasing square test pulses of 20-ms duration ranging from −60 to 50 mV every 5 s ([@bib49]).

Imaging
-------

We transfected HEK 293T cells with Ca~V~2.1-GFP (provided by E.S. Piedras-Renteria; [@bib10]) or Ca~V~2.2-GFP, both obtained by subcloning in pEGFP-C1 vector, its auxiliary subunits (Ca~V~α2δ1 and Ca~V~β3), and GHSR1a or GHSR1a-A204E as described previously. 48 or 24 h after transfection for Ca~V~2.1-GFP or Ca~V~2.2-GFP, respectively, we replaced the culture medium by 1 ml of 1 µg/ml of membrane marker solution (CellMask orange plasma membrane stain; Molecular probes) and kept the cells at 37°C for 1 min. Next, we washed three times with PBS. Finally, we removed almost all of the PBS volume and placed a clean coverslip over the cell layer. We obtained fluorescence photomicrographs with an optical fluorescence microscope (Eclipse 50i; Nikon), equipped with B2A and G2A filters and with a camera (DS-Ri1; Nikon). We performed the analysis on photomicrographs with FIJI free software, using the CellMask red signal to mark out the plasma membrane and quantify green fluorescence intensity in both the internal area (excluding plasma membrane) and the total area of each cell as integrated density. We calculated the fluorescence intensity corresponding to the membrane (membrane fluorescence) as the difference between the fluorescence corresponding to the total (total fluorescence) and the internal area. Then we calculated the percentage of Ca~V~2.1-GFP or Ca~V~2.2-GFP membrane fluorescence as = (membrane fluorescence/total fluorescence) × 100 for each cell.

Western blots
-------------

We used Lipofectamine Plus reagent (Invitrogen) to transfect HEK 293T cells with Ca~V~2.1 or Ca~V~2.2, the Ca~V~ channel auxiliary Ca~V~α~2~δ~1~ and Ca~V~β~3~ subunits, as well as the GHSR1a and the GHSR1a-A204E or the pCDNA3.1 empty vector. We extracted membrane protein using a membrane protein extraction kit (BioVision) as reported elsewhere ([@bib21]). For each condition, we used six 100-mm culture plates of HEK 293T cells expressing Ca~V~ channels. We determined cytosolic and plasma membrane protein concentration using the bicinchoninic acid assay. In brief, 40/50 µg of protein samples were boiled for 5 min in protein-loading buffer (1.7% SDS, 0.1 M 2-mercaptoethanol, 5% glycerol, 58 mM Tris-Cl, and 0.002% bromophenol blue, pH 6.8), resolved in 7% SDS-polyacrylamide gels, and transferred to nitrocellulose membranes (Immobilon; EMD Millipore). After blocking with 5% nonfat dry milk in Tris-buffered saline Tween 20 (TBST; 100 mM Tris-Cl, 0.9% \[wt/vol\] NaCl, and 0.2% Tween 20, pH 7.5), we incubated membranes overnight with primary antibodies: anti-Ca~V~2.1 (1:300 in TBST 2.5% milk; Alomone Labs), anti-Ca~V~2.2 (1:200 in TBST; EMD Millipore), anti-cadherin (1:200 in TBST; Invitrogen), anti-AKT (1:15,000 in TBST; Santa Cruz Biotechnology, Inc.), and anti-Hsp90 (1:2,000 in TBST; Cell Signaling Technology). Next, we washed membranes and incubated them with horseradish peroxidase (HRP)- conjugated secondary antibodies (anti--rabbit HRP; 1:5,000 in TBST; Jackson InmunoResearch Laboratories, Inc.; anti--mouse HRP; 1:5,000 in TBST; Jackson InmunoResearch Laboratories) diluted in TBST-5% nonfat dry milk. For semiquantitative analysis, we normalized Ca~V~ channel signal to the cadherin signal. We used ImageJ software (National Institutes of Health) for densitometry analysis.

Ex vivo determination of \[^3^H\]GABA release in arcuate nucleus (ARC)
----------------------------------------------------------------------

We euthanized ad libitum--fed and 48 h--fasted mice by live decapitation. We extracted brains, placed them briefly in cold PBS, and sectioned them into 1-mm coronal slices by using a stainless steel mouse brain matrix. We excised small punches of tissue corresponding to the known location of the ARC, as compared with the mouse brain atlas ([@bib47]), using a 15-gauge needle. We incubated the ARC microdissections on Krebs-Ringer bicarbonate buffer (KRBB) saturated with 95% O~2~ and 5% CO~2~ for 10 min at 37°C. Next, we incubated with \[^3^H\]GABA (367 cpm/ml, with a specific activity of 92.1 Ci/mmol; PerkinElmer) in KRBB for 20 min to fill synaptic vesicles with the tracer, and we performed two washes with KRBB. After that, we incubated ARC microdissections for 10 min with fresh KRBB containing 56 mM KCl. Finally, we collected the medium, mixed it with 150 µl scintillator (Ecolite), and measured the radioactivity in a β-counter (Tracor Analytic).

Quantitative real-time (qRT)-PCR analysis
-----------------------------------------

We euthanized ad libitum--fed and 48 h--fasted mice by live decapitation. We extracted brains, placed them briefly in cold diethylpyrocarbonate-PBS, and excised small punches of tissue corresponding to the ARC, as explained above. We then performed qRT-PCR analysis as described in [@bib12]. In brief, we isolated total RNA from these punches using RNA STAT-60 (Tel-Test, Inc.). We treated the RNA with RNase-free DNase (Roche) and reverse-transcribed it into cDNA with SuperScript II reagents (Invitrogen). We performed a quantitative PCR using a sequence detection system (7900HT; Applied Biosystems) and SYBR green chemistry (Applied Biosystems). Primers were mGHSR-QF1, 5′-ACCGTGATGGTATGGGTGTCG-3′, and mGHSR-QR1, 5′-CACAGTGAGGCAGAAGACCG-3′; they amplified a product within exon 2 of the ghsr gene. We confirmed these results by a second set of specific primers, one of which is located in exon 1 of the ghsr gene (mGHSR-QF3, 5′-ATCTCCAGTGCCAGGCACTGCT-3′) and the other of which is located in exon 2 (mGHSR-GR3, 5′-AATGGGCGCGAGCAGCAGGAA-3′) of the ghsr gene. The mRNA relative levels were expressed relative to the housekeeping gene 36B4 and calculated by the comparative threshold cycle (ΔΔCt) method ([@bib37]). The data are presented as a percentage of levels observed in wild-type ARC punches.

Drugs
-----

We used ghrelin esterified with *n*-octanoic acid (Global Peptide); a GHSR1a inverse agonist, \[[d]{.smallcaps}-Arg1,[d]{.smallcaps}-Phe5,[d]{.smallcaps}-Trp7,9,Leu11\]--substance P (SPA; Santa Cruz Biotechnology, Inc.); the inhibitor of G~s~ protein, cholera toxin (ChTx; Sigma Aldrich); a specific inhibitor of G~i/o~ protein, pertussis toxin (PTx; Sigma-Aldrich); the Ca~V~2.1 blocker, ω-agatoxin-IVA (Peptides International); and the Ca~V~2.2 blocker, ω-conotoxin-GVIA (Alomone Labs).

Statistics
----------

We analyzed and plotted the data using the OriginPro 8 (OriginLab) and GraphPad Prism 5 (GraphPad Software, Inc.) software. We examined the normal distribution of data by the Kolmogorov--Smirnov test. Based on the normality test results, we established statistical significance (P \< 0.05) by one- or two-sample *t* test (normal distributed data) or Mann--Whitney test (no normal distributed data), and multiple comparison ANOVA with Dunnett's or Tukey's post-test (normal distributed data) or nonparametric Kruskal--Wallis test with Dunn's post-test (no normal distributed data). The specific statistical test used is detailed in each case. We expressed data as mean ± SE with the number of observations in brackets.

RESULTS
=======

Constitutive and ghrelin-dependent GHSR1a activities differentially inhibit Ca~V~2 currents in a heterologous expression system
-------------------------------------------------------------------------------------------------------------------------------

We first examined the effect of GHSR1a and GHSR1a-A204E, a mutant lacking constitutive activity ([@bib46]), on cloned Ca~V~2.1 and Ca~V~2.2 channels. We coexpressed GHSR1a and Ca~V~2 in a 1:1 molar ratio (0.6 µg of receptor cDNA per transfection) and measured calcium currents in HEK 293T cells. Calcium currents were significantly smaller in cells coexpressing GHSR1a and Ca~V~2, as compared with those expressing Ca~V~2 alone. In contrast, Ca~V~2 currents in cells coexpressing GHSR1a-A204E were not different from control recordings. We next tested if agonist-independent GHSR1a-induced inhibition of Ca~V~2 varies with GHSR1a expression levels. Thus, we measured Ca~V~2 currents in cells transfected with Ca~V~2.1 or Ca~V~2.2 channels and different amounts of GHSR1a plasmid and found that Ca~V~2 current amplitudes were inversely proportional to GHSR1a cDNA amount per transfection ([Fig. 1 A](#fig1){ref-type="fig"}). Moreover, we found that F-ghrelin binding positively correlated with the level of GHSR1a cDNA used in the transfection ([Fig. 1 B](#fig1){ref-type="fig"}). Next, we measured basal Ca~V~2 currents in cells expressing GHSR1a with or without preincubation with the GHSR1a inverse agonist SPA (1 µM) for 16 h, and we found no significant difference with currents recorded in cells coexpressing GHSR1a-A204E ([Fig. 1 C](#fig1){ref-type="fig"}). To assess ghrelin-dependent GHSR1a action on Ca~V~2 currents, we used GHSR1a-A204E, which lacks constitutive activity but is prone to activation by agonist binding. The application of a saturating dose of ghrelin (0.5 µM; [@bib46]) inhibited both Ca~V~2 subtypes, but it was more effective on Ca~V~2.2 compared with Ca~V~2.1 currents (44.5 ± 6.9%, *n* = 8 vs. 15.4 ± 3.9%, *n* = 5, respectively, at 0.6 µg of receptor cDNA; *t* test; P = 0.01). Moreover, to test if the ghrelin-mediated effect was independent on GHSR1a expression levels and A204E mutation, we applied ghrelin in cells transfected with 0.15, 0.3, and 0.6 µg of GHSR1a- or 0.6 µg of GHSR1a-A204--containing cDNA per well and Ca~V~2.1 or Ca~V~2.2 and its auxiliary subunits. When 0.6 µg GHSR1a cDNA was used for transfections, we tested the effect of ghrelin only in cells that showed a measurable amount of current. We found that ghrelin-evoked GHSR1a activation inhibits Ca~V~2.1 and Ca~V~2.2 independently of A204E mutation and at the same extent in all the GHSR1a cDNA amounts tested ([Fig. 1 D](#fig1){ref-type="fig"}).

![Constitutive and ghrelin-dependent GHSR1a activity inhibit Ca~V~2 currents. (A) Representative I~Ca~ traces from HEK 293T cells transfected with Ca~V~2.1 or Ca~V~2.2, Ca~V~α~2~δ~1~, Ca~V~β~3~, and 0.6 µg GHSR1a, GHSR1a-A204E, or empty pcDNA3.1+ (control), and averaged I~Ca~ at different amounts of GHSR1a plasmid transfected. (B) Representative microphotographs (left) and average fluorescent signal intensity (right) for the F-ghrelin binding in cells transfected with increasing amounts of GHSR1a plasmid. (C) Representative I~Ca~ traces from cells cotransfected with Ca~V~2.1 and Ca~V~2.2, Ca~V~α~2~δ~1~, Ca~V~β~3~, and 0.6 µg GHSR1a or GHSR1a-A204E with or without 1 µM SPA preincubation (left), and the averaged I~Ca~ for each condition (right). (D) Time courses and representative traces of ghrelin effect on I~Ca~ from cells expressing Ca~V~2.1 or Ca~V~2.2, Ca~V~α~2~δ~1~, Ca~V~β~3~, and GHSR1a-A204E (left), and the averaged percentage of Ca~V~2.1 and Ca~V~2.2 current inhibition at different amounts of GHSR1a plasmid transfected. ANOVA with Dunnett's (C) and Tukey's post-test (D). \*, P \< 0.05. Error bars represent mean ± SE.](JGP_201511383R_Fig1){#fig1}

We obtained two more sets of evidence toward two differential inhibitory mechanisms of constitutive and ghrelin-evoked GHSR1a's effects on Ca~V~2 currents: ghrelin application inhibits calcium currents in HEK 293T cells expressing Ca~V~2.1 or Ca~V~2.2 and GHSR1a in a 1:1 molar ratio preincubated with SPA, despite the fact that constitutive GHSR1a activity is blocked ([Fig. 2 A](#fig2){ref-type="fig"}). In addition, we found that acute application of SPA was unable to remove Ca~V~2 inhibition by constitutive GHSR1a activity ([Fig. 2 B](#fig2){ref-type="fig"}).

![Constitutive GHSR1a activity inhibits by a long-term mechanism the Ca~V~2 currents preserving Ca~V~2 current inhibition by ghrelin-dependent GHSR1a activity. (A) Representative I~Ca~ traces (left) from HEK 293T cells expressing Ca~V~2.1 (above) or Ca~V~2.2 (below), Ca~V~α~2~δ~1~, Ca~V~β~3~, and GHSR1a preincubated with 1 µM SPA, before (control) and after (+ghrelin) 500-nM ghrelin application, and averaged percentage of I~Ca~ inhibition by 500 nM ghrelin (right) from HEK 293T cells expressing Ca~V~2.1 or Ca~V~2.2, Ca~V~α~2~δ~1~, Ca~V~β~3~, and GHSR1a preincubated with 1 µM SPA or GHSR1a-A204E as a control condition. (B) Time courses of peak Ca~V~2 currents (left) with the acute application of 1 µM SPA (gray bars) from HEK 293T cells expressing Ca~V~2.1 (above) or Ca~V~2.2 (below), Ca~V~α~2~δ~1~, Ca~V~β~3~, and GHSR1a, and the averaged Ca~V~2.1 or Ca~V~2.2 currents before (control) and after (+SPA) acute application of 1 µM SPA. Two sample (A) and paired (B) Student's *t* tests. Error bars represent mean ± SE.](JGP_201511383_Fig2){#fig2}

Thus, our data show that constitutive GHSR1a activity inhibits Ca~V~2.1 and Ca~V~2.2 channels by a long-term mechanism that depends on GHSR1a expression levels. In contrast, ghrelin-dependent GHSR1a activity is more effective to inhibit Ca~V~2.2 as compared with Ca~V~2.1 currents, and this inhibition is fast and independent of GHSR1a expression levels.

Two different signaling cascades are involved in Ca~V~2 inhibition by constitutive and ghrelin-dependent GHSR1a activities
--------------------------------------------------------------------------------------------------------------------------

Next, we tested the hypothesis that differential mechanisms mediate the inhibition of Ca~V~2 channels by constitutive and ghrelin-dependent GHSR1a activities. We examined the signaling pathways engaged by GHSR1a that result in Ca~V~2 inhibition. We first assessed the effectiveness of ghrelin-induced activation of GHSR1a-A204E on Ca~V~2.2 channels expressed in HEK 293T cells. Neither the G~s~ protein inhibitor ChTx (500 ng/ml) nor the G~i/o~ protein inhibitor PTx (500 ng/ml) affected ghrelin-mediated inhibition of Ca~V~2.2 currents ([Fig. 3 A](#fig3){ref-type="fig"}). We therefore used a mutant form of Gα~q~ (G~q~ dominant-negative mutant \[G~q~DN\]) that acts as a dominant negative interfering with G~q~-dependent signaling ([@bib64]; [@bib38]), and we found that G~q~DN occluded the inhibitory actions of ghrelin on Ca~V~2.2 ([Fig. 3 A](#fig3){ref-type="fig"}).

![Ca~V~2.2 inhibition by constitutive and ghrelin-dependent GHSR1a activity is signaled by G~i/o~ and G~q~ proteins, respectively. (A) Time course, representative traces, and averaged I~Ca~ inhibition by 500 nM ghrelin in HEK 293T cells transfected with Ca~V~2.2, Ca~V~α~2~δ~1~, Ca~V~β~3~, and GHSR1a-A204E in control conditions or preincubated with 500 ng/ml ChTx or 500 ng/ml PTx, or cotransfected with a G~q~DN. (B) Representative traces and averaged I~Ca~ in HEK 293T cells expressing Ca~V~2.2, Ca~V~α~2~δ~1~, Ca~V~β~3~, and GHSR1a or GHSR1a-A204E in control or preincubated with 500 ng/ml ChTx or 500 ng/ml PTx, or cotransfected with G~q~DN. (C) Representative traces and averaged I~Ca~ inhibition by 500 nM ghrelin in HEK 293T cells transfected with Ca~V~2.2, Ca~V~α~2~δ~1~, Ca~V~β~3~, and GHSR1a preincubated with 500 ng/ml PTx. (D) Representative I~Ca~ in HEK 293T cells cotransfected with Ca~V~2.2, Ca~V~α~2~δ~1~, GHSR1a-A204E, and Ca~V~β~3~ or Ca~V~β~2a~ without (control) or with (+ghrelin) 500 nM ghrelin without or with (+pp) an 80-mV prepulse application (left), and averaged percentage of I~Ca~ inhibition by 500 nM ghrelin in cells expressing Ca~V~2.2, Ca~V~α~2~δ~1~, and GHSR1a-A204E with the coexpression of Ca~V~β~3~ or Ca~V~β~2a~ and MAS-GRK2-ct and prepulse application (+pp; right). (E) Representative I~Ca~ traces from cells cotransfected with Ca~V~2.2, Ca~V~α~2~δ~1~, Ca~V~β~3~, and GHSR1a or GHSR1a-A204E with (+pp) or without (Control) the application of an 80-mV prepulse (left) and averaged I~Ca~ from HEK 293T cells expressing Ca~V~2.2, Ca~V~α~2~δ~1~, GHSR1a, or GHSR1a-A204E, with the coexpression of Ca~V~β~3~ or Ca~V~β~2a~ and MAS-GRK2ct and an 80-mV prepulse application (+pp; right). ANOVA with Dunnett's (A and B) or Tukey's post-test (D), and two-sample Student's *t* test (E). \*, P \< 0.05. Error bars represent mean ± SE.](JGP_201511383_Fig3){#fig3}

Then, we tested if the same G protein--signaling pathway also mediates the inhibitory actions of constitutive GHSR1a activity on Ca~V~2.2 currents independently of ghrelin. We found that neither G~q~DN nor pretreatment with ChTx affects Ca~V~2.2 current amplitude in cells expressing GHSR1a. In contrast, Ca~V~2.2 currents in cells coexpressing GHSR1a pretreated with PTx were not different from the currents recorded in cells coexpressing GHSR1a-A204E ([Fig. 3 B](#fig3){ref-type="fig"}). This result suggests that GHSR1a inhibits Ca~V~2.2 channels through G~i/o~ protein activation by an agonist-independent mechanism. Next, we incubated cells expressing the wild-type receptor GHSR1a with PTx, and then determine whether the agonist still modulates channel activity. We found that ghrelin inhibits the currents in this experimental condition, suggesting that the agonist-mediated and constitutive activity of GHSR1a modulates Ca~V~2 channels by two independent pathways ([Fig. 3 C](#fig3){ref-type="fig"}).

GPCR-mediated inhibition of Ca~V~2.2 is mediated for at least three different G proteins, and the downstream mechanisms can be voltage sensitive or voltage insensitive ([@bib65]). The most common form of G~i/o~-dependent inhibition of Ca~V~2.2 channels involves direct binding of G~βγ~ to the channel, and it is relieved by strong depolarizing prepulses (voltage sensitive) ([@bib25]; [@bib49]; [@bib39]). On the other hand, several G~α~ protein subtypes (G~q~, G~i/o~, and G~s~) activate voltage-insensitive forms of Ca~V~2 inhibition ([@bib28]; [@bib29]; [@bib65]; [@bib1]). We found that inhibition of Ca~V~2.2 channels by ghrelin-induced activation of GHSR1a-A204E is not relieved by 80-mV prepulses, consistent with a purely voltage-independent mechanism and a G~q~-mediated pathway ([Fig. 3 D](#fig3){ref-type="fig"}). However, it is known that G~q~-mediated inhibition of Ca~V~2.2 channels turns into a voltage-sensitive inhibition by substituting the Ca~V~β~3~ for a membrane-bound form, Ca~V~β~2a~ ([@bib31]). Thus, we assayed ghrelin-mediated inhibition of Ca~V~2.2 with Ca~V~β~2a~ as auxiliary subunit. We found that ghrelin-mediated inhibition of Ca~V~2.2 was not only reduced, as compared with the inhibition of Ca~V~2.2 channels formed by Ca~V~β~3~, but also completely reversed by 80-mV prepulses ([Fig. 3 C](#fig3){ref-type="fig"}). Moreover, we coexpressed the MAS-GRK2-ct peptide to sequester G~βγ~ ([@bib28]; [@bib49]) and found that this maneuver fully occluded the inhibitory actions of ghrelin--GHSR1a-A204E on Ca~V~2.2 channels coexpressed with either Ca~V~β~2a~ or Ca~V~β~3~. Collectively, our results demonstrate that ghrelin-mediated GHSR1a activation inhibits Ca~V~2.2 currents by a mechanism that involves G~q~, G~βγ~ subunits of G proteins whose voltage dependency relies on the Ca~V~β subtype. On the other hand, we found that inhibition of Ca~V~2.2 by constitutive GHSR1a activity is unaltered by strong prepulses to 80 mV, Ca~V~β subtype, or G~βγ~ sequestration ([Fig. 3 E](#fig3){ref-type="fig"}). Thus, our results suggest that agonist-dependent and agonist-independent forms of Ca~V~2.2 inhibition by GHSR1a signal through different pathways.

Ca~V~2 inhibition by constitutive GHSR1a activity is associated with a reduced channel density at the plasma membrane
---------------------------------------------------------------------------------------------------------------------

Based on our results showing that the GHSR1a inverse agonist, SPA, requires long preincubation periods to occlude constitutive inhibition of Ca~V~2 by GHSR1a, we decided to test if surface Ca~V~2 density was affected by constitutive GHSR1a activity. First, we monitored the presence of Ca~V~2 channels in the plasma membrane, using Ca~V~2.1 and Ca~V~2.2 channels tagged with GFP (Ca~V~2.1-GFP and Ca~V~2.2-GFP) that we have confirmed are functional in our experimental conditions (Ca~V~2.1-GFP current, −47.0 ± 14.5 pA/pF, *n* = 9; Ca~V~2.2-GFP current, −51.8 ± 12.3 pA/pF, *n* = 5). To identify the surface location of the GFP fluorescence signal, we used the red fluorescent membrane marker CellMask ([@bib14]). We found that Ca~V~2.1-GFP-- and Ca~V~2.2-GFP--associated fluorescence signal was significantly lower in cells coexpressing GHSR1a, as compared with those coexpressing GHSR1a-A204E or those coexpressing GHSR1a and preincubated with SPA or PTx ([Fig. 4 A](#fig4){ref-type="fig"}). Next, we used Western blots to confirm that the Ca~V~2.1 and Ca~V~2.2 membrane protein level is decreased when cells coexpress GHSR1a. We used HEK 293T cells transfected with Ca~V~2.1 or Ca~V~2.2, as well as GHSR1a, GHSR1a-A204E, or the pcDNA3.1 empty vector. By using cadherin as a plasma membrane marker, and AKT and Hsp90 as cytoplasmic protein markers, we found that Ca~V~2.1 and Ca~V~2.2 protein quantity decreased in the plasma membrane protein fraction when cells coexpress GHSR1a, whereas GHSR1a-A204E coexpression failed to affect the amount of Ca~V~2.1 and Ca~V~2.2 plasma membrane protein ([Fig. 4 B](#fig4){ref-type="fig"}). Collectively, our data suggest that constitutive GHSR1a activity reduces surface expression of Ca~V~2.1 and Ca~V~2.2 channels by a G~i/o~-dependent mechanism.

![GHSR1a decreases surface Ca~V~2.1 and Ca~V~2.2 density. (A) Photomicrographs and averaged percentages of green fluorescent plasma membrane signal of HEK 293T cells transfected with Ca~V~2.1-GFP (left) and Ca~V~2.2-GFP (right), its auxiliary subunits (Control) with GHSR1a or GHSR1a-A204E, and preincubated or not with 1 µM SPA or 500 ng/ml PTx. Green and red signals correspond to the eGFP tag on Ca~V~2 and the membrane marker CellMask, respectively. Kruskal--Wallis with Dunn's post-test; \*, P \< 0.01. (B) Western blot analysis displaying the Ca~V~2.1-GFP and Ca~V~2.2-GFP protein level in the plasma membrane (PM) or the cytoplasmic (Cyt) fraction of HEK 293T cells transfected with Ca~V~2.1-GFP or Ca~V~2.2-GFP and its auxiliary subunits (Control), and cotransfected with GHSR1a or GHSR1a-A204E (left), and averaged percentage of Ca~V~2.1-GFP and Ca~V~2.2-GFP PM protein level in each condition normalized against cadherin signal used as the plasma membrane loading control (right). Both AKT and Hsp90 as cytosolic markers. *n* = 2 and 3 for Ca~V~2.1-GFP or Ca~V~2.2-GFP, respectively. Error bars represent mean ± SE.](JGP_201511383_Fig4){#fig4}

Constitutive and ghrelin-dependent GHSR1a activities inhibit native N- and P/Q-type currents
--------------------------------------------------------------------------------------------

To test the effect of GHSR1a activities on calcium channels in native conditions, we used hypothalamic primary neuronal cultures of GHSR-eGFP reporter mice in which GHSR1a-expressing neurons are identifiable by green fluorescent signal ([@bib43]). We first compared Ca~V~ currents recorded in GHSR1a-positive (GHSR1a+) and GHSR1a-negative (GHSR1a−) neurons. Ca~V~ currents were inhibited by 100 µM CdCl~2~ (percentage of inhibition: GHSR1a+, 99.91 ± 2.51%, *n* = 5; GHSR1a−, 99.28 ± 0.98%, *n* = 5; both NS vs. 100%; *t* test; P \> 0.05). Ca~V~ currents recorded in GHSR1a+ neurons displayed the same voltage dependency as those recorded in GHSR1a− neurons, but they were significantly smaller ([Fig. 5, A and B](#fig5){ref-type="fig"}). Importantly, ghrelin application inhibited Ca~V~ currents in GHSR1a+ but not in GHSR1a− neurons ([Fig. 5 A](#fig5){ref-type="fig"}), and the effect was insensitive to 80-mV prepulse application, in agreement with our data in the expression system (percentage of I~Ba~ inhibition by ghrelin without 80-mV prepulse, 28.14 ± 6.16, and with 80-mV prepulse, 26.22 ± 7.27; NS; *n* = 4 neurons; P = 0.57; paired *t* test). We used ω-conotoxin-GVIA and ω-agatoxin-IVA to quantify the contribution of N- (Ca~V~2.2) and P/Q-type (Ca~V~2.1) channels, respectively, in this experimental system. We found that both current subtypes were significantly smaller in GHSR1a+ compared with GHSR1a− neurons in the presence or absence of ghrelin ([Fig. 5 C](#fig5){ref-type="fig"}). However, TTX-sensitive Na~V~ currents in GHSR1a+ and GHSR1a− neurons were not different (*t* test; P \> 0.05; [Fig. 5 D](#fig5){ref-type="fig"}). Thus, GHSR1a+ neurons have reduced N- and P/Q-type currents as compared with GHSR1a− neurons, and ghrelin inhibits those currents only in GHSR1a+ neurons.

![GHSR1a activity modulates native Ca~V~2 currents in hypothalamic neurons from GHSR-eGFP reporter mice. (A) Representative I~Ba~ traces and averaged I~Ba~ before (control) and after (+ghrelin) 500-nM ghrelin application in hypothalamic GHSR1a− and GHSR1a+ neurons. (B) Averaged peak I~Ba~--voltage (I-V) relationships (evoked from a holding of −80 mV), reversal (V~rev~), and activation (V~1/2~) potential midpoints (calculated by Boltzmann linear function) obtained from GHSR1a− and GHSR1a+ neurons. (C) I~Ba~ time courses of application of 1 µM ω-conotoxin-GVIA (conoTx) and 0.2 µM ω-agatoxin-IVA (agaTx) with or without previous 500-nM ghrelin application from hypothalamic GHSR1a− (top) and GHSR1a+ neurons (middle and bottom; left). Averaged percentage of I~Ba~ sensitive to agaTx and conoTx from GHSR1a− and GHSR1a+ neurons, with (+ghrelin) or without 500-nM ghrelin application (right). (D) Representative and averaged I~Na~ from GHSR1a− and GHSR1a+ neurons. Paired (A) or two-sample (B and D) Student's *t* test and ANOVA with Dunnett's post-test (C). \*, P \< 0.05. Error bars represent mean ± SE.](JGP_201511383_Fig5){#fig5}

To dissociate the effect of constitutive and ghrelin-dependent GHSR1a activities on native calcium channels, we transfected either GHSR1a-YFP or GHSR1a-A204E-YFP in hypothalamic rat-cultured neurons, which express minimal levels of endogenous GHSR1a under our experimental conditions (6 ± 2% of neurons bind F-ghrelin; *n* = 3 independent cultures). Ca~V~ currents recorded in neurons expressing GHSR1a-YFP were significantly smaller as compared with those recorded in either neurons expressing eGFP or GHSR1a-A204E-YFP neurons ([Fig. 6 A](#fig6){ref-type="fig"}). Ghrelin inhibited the same relative percentage of Ca~V~ currents in neurons expressing either GHSR1a-YFP or GHSR1a-A204E-YFP, whereas it failed to affect Ca~V~ currents in neurons expressing eGFP or nontransfected neurons ([Fig. 6 B](#fig6){ref-type="fig"}; normalized current traces). We next used ω-conotoxin-GVIA and ω-agatoxin-IVA to test Ca~V~2 subtype contribution to the total Ca~V~ current in our experimental conditions. We found a smaller contribution of Ca~V~2.1 and Ca~V~2.2 in GHSR1a-YFP--expressing neurons as compared with the contribution found in GHSR1a-A204E-YFP--expressing neurons. Additionally, calcium currents in the presence of ghrelin showed a reduced contribution of Ca~V~2 in both GHSR1a-YFP-- and GHSR1a-A204E-YFP--expressing neurons ([Fig. 6 C](#fig6){ref-type="fig"}). Importantly, TTX-sensitive Na~V~ currents were not affected among the different experimental conditions ([Fig. 6 D](#fig6){ref-type="fig"}). Thus, constitutive and ghrelin-dependent GHSR1a activities inhibit native N- and P/Q-type calcium currents in hypothalamic neurons.

![GHSR1a activity inhibits native Ca~V~2 currents from rat hypothalamic neurons. (A) Representative and averaged I~Ba~ from nontransfected (nt) and GFP-, GHSR1a-YFP--, and GHSR1a-A204E-YFP--transfected neurons. (B) Normalized I~Ba~ traces before (control) and after (+ghrelin) 500-nM ghrelin application, and averaged percentage of I~Ba~ inhibition by ghrelin in each condition. (C) I~Ba~ time courses of application of 1 µM ω-conotoxin-GVIA (conoTx) and 0.2 µM ω-agatoxin-IVA (agaTx) with or without previous 500-nM ghrelin application from GFP-, GHSR1a-, and GHSR1a-A204E--transfected neurons (left). Averaged percentage of I~Ba~ sensitive to agaTx and conoTx from nontransfected (nt), GFP-, GHSR1a-, and GHSR1a-A204E--transfected neurons, with (+ghrelin) or without 500-nM ghrelin application (right). (D) Representative and averaged I~Na~ from nontransfected (nt) and GFP-, GHSR1a-, and GHSR1a-A204E--transfected neurons. ANOVA with Dunnett's post-test (A--D). \*, P \< 0.05. Error bars represent mean ± SE.](JGP_201511383_Fig6){#fig6}

Constitutive and ghrelin-dependent GHSR1a activities reduce GABA release from hypothalamic explants
---------------------------------------------------------------------------------------------------

In previous studies, we have suggested that GHSR1a activity decreases inhibitory tone on hypothalamic neurons ([@bib7]). Thus, we next evaluated if GHSR1a activity affects GABA release from explants of the ARC, a hypothalamic nucleus where GHSR1a is highly expressed ([@bib66]) and GABA release is essential for food intake regulation ([@bib62]). To explore the role of constitutive GHSR1a activity, we used 48 h--fasted mice, in which hypothalamic GHSR1a mRNA levels were 1.5-fold higher compared with levels found in ad libitum--fed mice ([Fig. 7 A](#fig7){ref-type="fig"}, right). We studied the \[^3^H\]GABA release from explants of ARC, and we found a significant reduction of \[^3^H\]GABA release stimulated by high K^+^ in explants from fasted mice as compared with release detected in explants from ad libitum--fed mice ([Fig. 7 A](#fig7){ref-type="fig"}, left). Thus, our data show that fasting-induced increase of GHSR1a expression levels correlates with an inhibition of GABA release from ARC neurons.

![GHSR1a activity impacts GABA release. (A) \[^3^H\]GABA release (left) and GHSR1a mRNA levels (right) from ARC-enriched explants from ad libitum--fed or 48 h--fasted mice. (B) Representative traces and averaged IPSC size obtained from GHSR-null primary cultured neurons transduced or not with GHSR1a-YFP and GHSR1a-A204E-YFP. (C) Representative normalized traces with or without the application of 500 nM ghrelin, and average values of percentage of IPSC inhibition by ghrelin obtained from GHSR-null primary cultured neurons transduced or not with GHSR1a-YFP and GHSR1a-A204E-YFP. (D) Distribution of mIPSC size and averaged values for mIPSC frequencies and charge movement by 0.5-M sucrose solution application in GHSR-null primary cultured neurons transduced or not with GHSR1a-YFP and GHSR1a-A204E-YFP. Two-sample Student's *t* test (A) and ANOVA with Dunnett's post-test (B--D). \*, P \< 0.05. Error bars represent mean ± SE.](JGP_201511383_Fig7){#fig7}

To test if constitutive GHSR1a activity--displayed inhibition of N- and P/Q-type currents has an impact on GABA release, we recorded IPSCs in hypothalamic neuronal cultures from GHSR-null mice transduced with either GHSR1a-YFP or GHSR1a-A204E-YFP lentiviral vectors, which allow a high percentage of GHSR1a-expressing neurons. In these experimental conditions, we found a reduced IPSC size triggered by electrical stimulation in GHSR1a-YFP--expressing cultures compared with both GHSR1a-A204E-YFP--expressing cultures and nontransduced cultures ([Fig. 7 B](#fig7){ref-type="fig"}). Moreover, we found that acute ghrelin application reduced by ∼20% the IPSC peak in cultures expressing either GHSR1a-YFP or GHSR1a-A204E-YFP ([Fig. 7 C](#fig7){ref-type="fig"}; normalized IPSC recordings), indicating that both GHSR1a variants are functional and that ghrelin-dependent GHSR1a activation can further inhibit IPSCs. Finally, we recorded GABAergic postsynaptic responses stimulated by hyperosmotic solution in the presence of TTX, a maneuver known to release neurotransmitter in a Ca~V~-independent manner. We found no differences in these responses among nontransduced, GHSR1a-YFP--transduced, and GHSR1a-A204E-YFP--transduced cultures, suggesting that constitutive GHSR1a activity exclusively affects action potential--dependent and Ca~V~2-mediated GABAergic neurotransmission. Importantly, the size of spontaneous IPSCs was not different among conditions ([Fig. 7 D](#fig7){ref-type="fig"}), indicating the lack of postsynaptic effects in the IPSC size reduction by GHSR1a activity.

DISCUSSION
==========

We present evidence that GHSR1a, the GPCR with the highest constitutive activity, down-regulates Ca~V~2.1 and Ca~V~2.2 currents by a mechanism that is independent of its endogenous agonist, ghrelin, and involves G~i/o~ signaling and plasma membrane channel density reduction. We also show that ghrelin inhibits native and cloned Ca~V~2.1 and Ca~V~2.2 currents via activation of GHSR1a by a different signaling cascade that involves G~q~ protein activation. These two fundamentally different mechanisms could differentially contribute to regulate presynaptic Ca^2+^ entry and transmitter release from hypothalamic neurons.

Presynaptic Ca~V~2 channel inhibition by GPCRs is an important mechanism mediating the effects of many transmitters and drugs that control neurotransmitter release ([@bib11]). GHSR1a is expressed at axonal terminals, and a presynaptic role for this receptor has been suggested ([@bib15]; [@bib16]; [@bib63]; [@bib52]). In general, the ghrelin--GHSR1a system stimulates electrical and transcriptional activity in neurons ([@bib15]; [@bib4]; [@bib56]). Also, it has been shown that GHSR1a signaling augments cytosolic Ca^2+^ levels in hypothalamic neurons ([@bib24]; [@bib13]; [@bib63]). Here, we propose a novel mechanism that could potentially contribute to neuronal activation of hypothalamic neurons by controlling Ca~V~2 channels located at the presynaptic terminals of inhibitory input neurons. Moreover, in agreement with previous data showing that GHSR1a can couple to several different pathways, we demonstrate that two fundamentally different mechanisms govern ghrelin-dependent and ghrelin-independent Ca~V~2 inhibition by GHSR1a.

We show evidence that constitutive GHSR1a activity down-regulates Ca~V~2 channel density by a G~i/o~-dependent signaling pathway. GHSR1a is typically thought to involve G~q~ protein activation ([@bib23]), although G~i/o~ involvement is also well documented ([@bib6]). Other GPCRs, such as the nociceptin receptor (opioid receptor--like 1 \[ORL1\]) and metabotropic glutamate receptor subtype 1, have been shown to inhibit Ca~V~2 by agonist-binding independent mechanisms that require GPCR and channel protein direct interaction ([@bib36]; [@bib5]). ORL1 is a G~i/o~-coupled receptor that inhibits Ca~V~2.2 channels in dorsal root ganglion neurons, and it has been shown that basal and nociceptin-mediated ORL1 inhibition of Ca~V~2.2 shared a G~βγ~-mediated pathway, as both are avoided by G~βγ~ sequestering or depolarizing prepulse voltage application ([@bib5]). In contrast, here we show that Ca~V~2 current inhibition by constitutive GHSR1a activity differs from ghrelin-evoked effect, as the former mode of inhibition is independent of G~βγ~ binding and unaffected by a depolarizing prepulse.

The long-lasting inhibition of Ca~V~2 currents by GHSR1a constitutive activity implicates channel density reduction at the plasma membrane. Several GPCRs, including dopamine receptors and ORL1, use mechanisms involving channel internalization to impact Ca~V~2 currents in the long term ([@bib2]; [@bib34]; [@bib35]). In a clear demonstration of complexity in channel activity regulation by GPCRs, these receptors can inhibit the channels by voltage-dependent and voltage-independent modulation, as well as by cointernalization resulting from direct interaction between the activated receptor and the channel. We cannot discard the direct interaction between the GHSR1a and Ca~V~2 channels in the mechanism involved in channel density reduction by GHSR1a constitutive activity. If present, however, this mechanism is likely insufficient to mediate channel density reduction, as protein G~i/o~ activation is required for the effect. The molecular mechanism by which GHSR1a-mediated G~i/o~ basal activation modifies channel density is unclear with our present data. We postulate that a reduced channel trafficking is a more suitable hypothesis over channel internalization, given the long-term effect of the GHSR1a inverse agonist (see [Fig. 2 B](#fig2){ref-type="fig"}) and the particular distribution of fluorescence signal from Ca~V~2-GFP around the nucleus of transfected HEK 293T cells (see [Fig. 4 A](#fig4){ref-type="fig"}). More experiments are required to determine the intermediate molecular players of this pathway. Thus, there is increasing evidence that channel-trafficking regulation from and toward the plasma membrane could be universal mechanisms that GPCRs use to control voltage-gated calcium currents in neurons.

We found that ghrelin-dependent GHSR1a activity inhibits Ca~V~2 channels by a rapid and reversible G~q~-dependent signaling pathway. G~q~ activation generally inhibits Ca~V~2 in a voltage-independent manner. Several signaling pathways have been proposed to mediate calcium channel inhibition, including PtdIns(4,5)P~2~ depletion from plasma membrane, increase of arachidonic acid production, and protein kinases activation ([@bib61]; [@bib41]; [@bib20]; [@bib57]). The Ca~V~2 inhibition induced by PtdIns(4,5)P~2~ depletion or arachidonic acid increment requires cytoplasmic subtypes of Ca~V~β (Ca~V~β~3~) and, as a consequence, both mechanisms fail to impair Ca~V~2 currents if channels contain the membrane-anchored form of Ca~V~β, Ca~V~β~2a~ ([@bib22]; [@bib58]). Accordingly, we found that the inhibition of Ca~V~2.2 induced by ghrelin-evoked GHSR1a activation depends on the type of Ca~V~β subunit. In particular, the ghrelin-mediated Ca~V~2.2 inhibition was significantly reduced and fully voltage dependent when Ca~V~β~2a~ was present, whereas it was larger and voltage independent in the presence of Ca~V~β~3~. Additionally, we found that buffering G~βγ~ is enough to completely avoid the ghrelin-mediated inhibition of Ca~V~2.2 independently of the Ca~V~β subtype. Previous reports have shown the same dependency of G~βγ~ for other G~q~PCR-mediated pathways (i.e., muscarinic type 1 and neurokinin type 1 receptors; [@bib29]). Thus, our data support the notion that Ca~V~β~2a~ in the channel complex switches the voltage dependency of Ca~V~2 inhibition by occluding G~q~ subunit--signaled effect and unmasks the inhibition by G~βγ~ direct binding, as recently demonstrated by [@bib31].

Peripheral administration of ghrelin potently increases food intake ([@bib45]). Plasma ghrelin almost exclusively accesses the hypothalamic ARC, which expresses high levels of GHSR1a and is required for the orexigenic actions of peripheral ghrelin ([@bib66]; [@bib54]; [@bib9]). GABA release from ARC neurons is essential for food intake regulation ([@bib62]), and GHSR1a is found at presynaptic terminals ([@bib15]; [@bib63]). It has also been shown that GABA release by AgRP ARC neurons is required for ghrelin-induced food intake ([@bib59]), and a ghrelin-induced reduction of GABA release has been proposed to mediate other hypothalamic actions of the hormone ([@bib7]). Thus, current results showing that ghrelin-induced GHSR1a activity inhibits native calcium channels, impairs Ca~V~2-dependent GABA release from ARC explants, and modifies synaptic activity in hypothalamic neurons in culture offer a molecular mechanism that could mediate well-established effects of ghrelin. In contrast, the physiological role of constitutive GHSR1a activity has been hard to highlight in in vivo settings. Here, we confirmed that GHSR1a expression level is affected by the energy balance conditions, and found that this change correlates with GABA release from ARC explants, suggesting that GHSR1a constitutive activity may have functional implications ([@bib23]; [@bib32]; [@bib46]; [@bib33]; [@bib40]). The fact that in vivo administration of the GHSR1a inverse agonist SPA reduces food intake and body weight in rats ([@bib48]), and that mice lacking GHSR1a exhibit a more severe phenotype as compared with ghrelin knockout mice, has also been interpreted as indications of a physiological role of the constitutive GHSR1a activity ([@bib60]). Notably, the A204E mutation has been associated with short stature and dominant transmission in human beings ([@bib46]). However, further studies are required to explore the physiological implications of the GHSR1a-related molecular events that occur in a ghrelin-independent fashion.

Current data open many intriguing questions including the physiological relevance of constitutive activity at synapses without ghrelin availability and mechanisms that regulate the agonist-independent actions of GHSR1a. Interestingly, GHSR1a is also present in the brain areas distant from circumventricular organs ([@bib66]) that are not accessed by plasma ghrelin ([@bib8], [@bib9]). It has been proposed that GHSR1a located in obviously inaccessible areas to plasma ghrelin could be modulated by centrally produced ghrelin ([@bib15]); however, more recent studies have clearly shown that ghrelin is not synthesized in the central nervous system ([@bib53]; [@bib19]). Besides receptor expression levels, heterodimerization of GHSR1a with other GPCRs could also serve as an alternative mechanism to modulate specific functions of this receptor, independently of ghrelin binding ([@bib26]; [@bib51]; [@bib30]; [@bib55]). Thus, more efforts will be required to get insight on the complexity of the GHSR1a/actions in neurons.
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